Evaluation of timed dexamethasone eye drops to prevent proliferative retinopathy of prematurity : a study protocol for a randomized intervention, multi-centre, double-blinded trial (DROPROP)
Background: As the survival rate of preterm infants continues to rise worldwide, more infants are at risk of developing sight-threatening retinopathy of prematurity (ROP). Destructive retinal laser treatment and intravitreal injections of anti-vascular endothelial growth factor (VEGF), factor, which have potential systemic side effects, are necessary to prevent blindness in severe cases of ROP. Of
